Bennett Associates Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$520K Sell
1,479
-138
-9% -$49.2K 0.35% 31
2025
Q4
$529K Buy
1,617
+12
+0.7% +$3.81K 0.37% 30
2025
Q3
$453K Buy
1,605
+200
+14% +$58K 0.33% 30
2025
Q2
$392K Sell
1,405
-104
-7% -$29.5K 0.3% 31
2025
Q1
$470K Sell
1,509
-111
-7% -$32.8K 0.39% 26
2024
Q4
$422K Buy
+1,620
New +$481K 0.35% 30
2024
Q3
Sell
-1,655
Closed -$517K 46
2024
Q2
$517K Sell
1,655
-127
-7% -$37.3K 0.47% 24
2024
Q1
$507K Buy
1,782
+138
+8% +$40.4K 0.46% 25
2023
Q4
$474K Buy
+1,644
New +$448K 0.46% 27

Other funds holding AMGN

Bennett Associates Wealth Management's AMGN Position: Q1 2026 in Review

Bennett Associates Wealth Management reduced its Amgen (AMGN) stake by 8.5% in Q1 2026, selling an estimated $49.2K and leaving 1,479 shares worth $520K. The position accounts for 0.35% of the portfolio, ranked #31.

Bennett Associates Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 9 quarters since. The position peaked at $529K in Q4 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bennett Associates Wealth Management held 1,479 shares of Amgen worth $520K as of Q1 2026.
  • Bennett Associates Wealth Management sold 138 Amgen shares in Q1 2026, an estimated $49.2K.
  • Amgen made up 0.35% of Bennett Associates Wealth Management's portfolio in Q1 2026, its #31 holding.
  • Bennett Associates Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 9 quarters since.
  • Bennett Associates Wealth Management's Amgen position peaked at $529K in Q4 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bennett Associates Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.